UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 544

Sortiert nach

Bone health in cancer patients: ESMO Clinical Practice Guidelines

Annals of oncology, 2014-09, Vol.25 Suppl 3, p.iii124-iii137

2014

Volltextzugriff (PDF)

Management of breast cancer in elderly patients

Breast (Edinburgh), 2021-04, Vol.56, p.S14-S15

Aapro, M.

2021

Volltextzugriff (PDF)

Biosimilars in oncology: much ado about nothing?

Annals of oncology, 2018-01, Vol.29 (1), p.25-26

Aapro, M.

2018

Volltextzugriff (PDF)

Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives

Supportive care in cancer, 2020-10, Vol.28 (10), p.4589-4612

2020

Volltextzugriff (PDF)

Bone health in cancer: ESMO Clinical Practice Guidelines

Annals of oncology, 2020-12, Vol.31 (12), p.1650-1663

2020

Volltextzugriff (PDF)

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

European journal of cancer (1990), 2011-01, Vol.47 (1), p.8-32

2011

Volltextzugriff (PDF)

Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review

Annals of oncology, 2015-06, Vol.26 (6), p.1081-1090

2015

Volltextzugriff (PDF)

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

Annals of oncology, 2016-09, Vol.27 (suppl 5), p.v119-v133

2016

Volltextzugriff (PDF)

The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting

Annals of oncology, 2017-06, Vol.28 (6), p.1260-1267

2017

Volltextzugriff (PDF)

European Society for Medical Oncology (ESMO) position paper on supportive and palliative care

Annals of oncology, 2018-01, Vol.29 (1), p.36-43

2018

Volltextzugriff (PDF)

Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients

European journal of cancer (1990), 2019-07, Vol.116, p.116-136

2019

Volltextzugriff (PDF)

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines

Annals of oncology, 2016-09, Vol.27 (suppl 5), p.v111-v118

2016

Volltextzugriff (PDF)

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

European journal of cancer (1990), 2007-01, Vol.43 (2), p.258-270

2007

Volltextzugriff (PDF)

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

Annals of oncology, 2014-07, Vol.25 (7), p.1328-1333

2014

Volltextzugriff (PDF)

Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force

Annals of oncology, 2014-08, Vol.25 (8), p.1492-1499

2014

Volltextzugriff (PDF)

Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment

Annals of oncology, 2011-12, Vol.22 (12), p.2546-2555

2011

Volltextzugriff (PDF)

Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013

Annals of oncology, 2015-03, Vol.26 (3), p.463-476

2015

Volltextzugriff (PDF)

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)

Annals of oncology, 2018-02, Vol.29 (2), p.452-458

2018

Volltextzugriff (PDF)

Practical guidance for the management of aromatase inhibitor-associated bone loss

Annals of oncology, 2008-08, Vol.19 (8), p.1407-1416

2008

Volltextzugriff (PDF)

Aprepitant: drug–drug interactions in perspective

Annals of oncology, 2010-12, Vol.21 (12), p.2316-2323

2010

Volltextzugriff (PDF)

The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)

Annals of oncology, 2012-08, Vol.23 (8), p.1986-1992

2012

Volltextzugriff (PDF)

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

Annals of oncology, 2018-10, Vol.29 (Supplement_4), p.iv96-iv110

2018

Volltextzugriff (PDF)

Emerging topics in anaemia and cancer

Annals of oncology, 2012-09, Vol.23 Suppl 10, p.x289-x293

Aapro, M

2012

Volltextzugriff (PDF)

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

Annals of oncology, 2006-09, Vol.17 (9), p.1441-1449

2006

Volltextzugriff (PDF)

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

Annals of oncology, 2010-05, Vol.21 (suppl-5), p.v232-v243

2010

Volltextzugriff (PDF)

1 – 25 von 544

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(514)
Mit Volltextzugriff
(476)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(319)
Life Sciences & Biomedicine
(289)
Science & Technology
(289)
Oncology
(268)
Female
(151)
Biological And Medical Sciences
(132)
Medical Sciences
(131)
Aged
(127)
Male
(89)
Middle Aged
(88)
Pharmacology. Drug Treatments
(88)
Antineoplastic Agents - Adverse Effects
(73)
Hematology, Oncology And Palliative Medicine
(70)
Chemotherapy
(69)
Adult
(68)
Neoplasms - Drug Therapy
(60)
Antineoplastic Agents
(59)
Tumors
(57)
Vomiting - Chemically Induced
(56)
Breast Neoplasms - Drug Therapy
(47)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(127)
European Journal Of Cancer
(63)
Journal Of Clinical Oncology
(37)
Critical Reviews In Oncology/hematology
(34)
Supportive Care In Cancer
(20)
Breast
(17)
European Journal Of Cancer Supplements
(16)
Revue Médicale Suisse
(16)
British Journal Of Cancer
(12)
Oncologie
(11)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Bone health in cancer patients: ESMO Clinical Practice Guidelines

Management of breast cancer in elderly patients

Biosimilars in oncology: much ado about nothing?

Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives

Bone health in cancer: ESMO Clinical Practice Guidelines

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours

Recent developments in the prevention of chemotherapy-induced nausea and vomiting (CINV): a comprehensive review

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients

The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting

European Society for Medical Oncology (ESMO) position paper on supportive and palliative care

Updated recommendations of the International Society of Geriatric Oncology on prostate cancer management in older patients

Management of febrile neutropaenia: ESMO Clinical Practice Guidelines

EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update

A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy

Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force

Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment

Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013

A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC)

Practical guidance for the management of aromatase inhibitor-associated bone loss

Aprepitant: drug–drug interactions in perspective

The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER)

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

Emerging topics in anaemia and cancer

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

Suchergebnisse filtern